It’s been five years since Angelina Jolie announced to the world she carries a BRCA1 mutation and had a prophylactic double mastectomy to lower her risks of developing breast cancer. Below advocates reflect on the impact she has made by sharing her story and...
The National Comprehensive Cancer Network (NCCN) provides guidelines to help determine who should have genetic testing for hereditary cancers and how individuals should be followed after testing. They recently published updates to these guidelines that we’ve...
When we read about genetic testing in the mainstream media, we often think of the testing Angelina Jolie had, called germline genetic testing. This analysis looks for genetic variants (differences) in our DNA that we are born with and are found in most of the cells in...